Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity.
polymeric nanoparticles
submicrometric particles
vaccine
visceral leishmaniasis
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
31 Jul 2023
31 Jul 2023
Historique:
received:
26
04
2023
revised:
13
07
2023
accepted:
18
07
2023
medline:
26
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
Recent studies suggest that the association of antigens in microparticles increases the anti-
Identifiants
pubmed: 37631877
pii: vaccines11081309
doi: 10.3390/vaccines11081309
pmc: PMC10459565
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Curr Opin Immunol. 2000 Aug;12(4):456-63
pubmed: 10899018
Nature. 1998 Mar 19;392(6673):245-52
pubmed: 9521319
J Drug Deliv. 2011;2011:181646
pubmed: 21773041
Chem Soc Rev. 2016 Jan 7;45(1):152-68
pubmed: 26487097
Vaccine. 2008 Jul 23;26(31):3922-31
pubmed: 18555567
Nat Rev Microbiol. 2007 Nov;5(11):873-82
pubmed: 17938629
Mol Pharm. 2012 Jan 1;9(1):81-90
pubmed: 22149016
PLoS One. 2012;7(7):e40745
pubmed: 22829882
Parasitol Res. 2012 Jul;111(1):105-14
pubmed: 22223037
Rev Inst Med Trop Sao Paulo. 1962 May-Jun;4:198-212
pubmed: 13884626
Int J Nanomedicine. 2011;6:835-42
pubmed: 21589651
Vaccine. 2007 Nov 1;25(44):7674-86
pubmed: 17913311
J Control Release. 2015 Jul 10;209:207-18
pubmed: 25931305
Vaccine. 1999 Sep;18(3-4):209-15
pubmed: 10506644
Front Cell Infect Microbiol. 2021 Mar 17;11:643953
pubmed: 33816349
Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111684
pubmed: 33545846
Expert Rev Vaccines. 2012 Jan;11(1):69-86
pubmed: 22149710
Vaccine. 2006 Apr 12;24 Suppl 2:S2-30-1
pubmed: 16823914
Vaccine. 2007 Mar 1;25(11):2085-94
pubmed: 17258843
Vaccines (Basel). 2015 Apr 16;3(2):320-43
pubmed: 26343190
PLoS One. 2012;7(11):e49780
pubmed: 23189161
ACS Cent Sci. 2017 Sep 27;3(9):1026-1031
pubmed: 28979944
PLoS Negl Trop Dis. 2018 May 14;12(5):e0006496
pubmed: 29758031
Nat Rev Drug Discov. 2021 Jun;20(6):454-475
pubmed: 33824489
Vaccines (Basel). 2020 Jun 09;8(2):
pubmed: 32526867
Trends Immunol. 2015 Jul;36(7):419-27
pubmed: 26088391
Microbes Infect. 2022 Mar;24(2):104884
pubmed: 34487860
Acta Trop. 2013 Dec;128(3):528-35
pubmed: 23916506
Front Immunol. 2019 Nov 26;10:2749
pubmed: 31849951
Acta Biomater. 2017 Jan 15;48:41-57
pubmed: 27826003
Nat Immunol. 2004 Oct;5(10):987-95
pubmed: 15454922
Eur J Pharm Sci. 2013 Jun 14;49(3):371-81
pubmed: 23542495
Int J Biol Macromol. 2022 Mar 1;200:498-519
pubmed: 34973993
Comp Immunol Microbiol Infect Dis. 2004 Sep;27(5):305-18
pubmed: 15225981
Parasit Vectors. 2014 Feb 07;7:61
pubmed: 24507702
Vaccine. 2011 Feb 17;29(9):1812-23
pubmed: 21215831
Evid Based Complement Alternat Med. 2011;2011:182703
pubmed: 20007259
Nat Biotechnol. 1999 Nov;17(11):1075-81
pubmed: 10545912
Cells. 2021 Aug 17;10(8):
pubmed: 34440875
Trop Biomed. 2010 Dec;27(3):639-50
pubmed: 21399606
Nanomedicine (Lond). 2014 Dec;9(17):2671-81
pubmed: 25529570
Res Vet Sci. 2008 Aug;85(1):106-12
pubmed: 17950391
Expert Rev Vaccines. 2019 May;18(5):505-521
pubmed: 31009255
Immunity. 2010 Oct 29;33(4):492-503
pubmed: 21029960
Drug Discov Today. 2011 Jul;16(13-14):569-82
pubmed: 21570475
Eur J Pharm Sci. 2017 Jul 15;105:19-32
pubmed: 28442440
Eur J Pharm Sci. 2012 Feb 14;45(3):282-95
pubmed: 22155747
PLoS One. 2012;7(6):e38859
pubmed: 22715418
PLoS One. 2011 Jan 26;6(1):e16333
pubmed: 21298114
Biomed Pharmacother. 2018 Sep;105:616-624
pubmed: 29894962
Front Immunol. 2012 Aug 14;3:251
pubmed: 22912637
Lancet. 2005 Oct 29-Nov 4;366(9496):1561-77
pubmed: 16257344